Skip to content

Research Explainer

Compounded GLP-1s: what FDA says.

Compounded versions of GLP-1 medicines are part of a fast-moving conversation about access and cost. Here is what the U.S. Food & Drug Administration says about them.

Compounded drugs are not FDA approved

FDA says compounded drugs are not FDA approved, which means the agency does not review them for safety, effectiveness, or quality before they are marketed.[1]

When FDA says compounding may fit

According to FDA, a compounded drug might be appropriate if a patient’s medical need cannot be met by an FDA-approved drug, or the approved drug is not commercially available.[1]

Concerns FDA has raised

FDA has identified areas of concern for compounded GLP-1 drugs. For multi-dose vials, it advises not to keep using medication from a vial after 28 days, even if the compounder’s instructions say otherwise.[1]

What this does not answer

It does not evaluate any specific compounder, pharmacy, or telehealth platform. Individual decisions and support needs belong with a qualified healthcare professional.

This page is for general education and event programming. It does not provide medical advice, diagnose conditions, recommend treatment, or endorse a medication, provider, product, or service.

Sources

  1. [1]FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food & Drug AdministrationRead the source (opens in a new tab)